GTHP — GUIDED THERAPEUTICS INC
—
OTC ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 924515 ·
Last close
$0.20
Market Cap
$19.60M
52W High
$0.30
52W Low
$0.17
ADV30
11,057
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | 0 | -302,000 | -500,000 | 1,604,000 | 369,000 | 6,780,000 |
| Dec 2025 | 590,000 | 458,000 | -710,000 | -1,218,000 | 1,324,000 | 63,000 | 7,330,000 |
| Sep 2025 | 60,000 | 35,000 | -485,000 | -742,000 | 903,000 | 87,000 | 6,549,000 |
| Jun 2025 | 117,000 | 79,000 | -763,000 | -811,000 | 940,000 | 185,000 | 6,412,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,354,000
Investing CF
$0
Financing CF
$1,610,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.04
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-158,068,000
Inventory
$469,000
Receivables
$4,000
ST Investments
—
EBIT TTM
$-2,650,000
Pretax Income TTM
$-3,271,000
Interest Exp TTM
$621,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$767,000
EBITDA
$-2,250,000
Free Cash Flow
$-880,625
Enterprise Value
$22,705,948
Total Cash
$369,000
Total Debt
$2,785,000
Shares Out
96,537,349
Trailing EPS
$-0.04
Book Value
$-0.06
ROE
—
ROA
-109.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 767,000 | -2,372,000 | -3,196,000 | 1,324,000 | 7,330,000 | — | -1,068,000 |
| Dec 2024 | 7,000 | -2,108,000 | -2,417,000 | 1,378,000 | 6,267,000 | — | -1,119,000 |
| Dec 2023 | 98,000 | -3,457,000 | -3,489,000 | 1,669,000 | 5,475,000 | — | -1,746,000 |
| Dec 2022 | 13,000 | -3,333,000 | -4,341,000 | 3,366,000 | 6,249,000 | — | -1,479,000 |
| Dec 2021 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IRIX | IRIDEX CORP | $19.50M | $1.12 | — |
| LFWD | Lifeward Ltd. | $19.08M | $6.78 | — |
| HRGN | Harvard Apparatus Regenerative Technology, Inc. | $18.99M | $1.08 | — |
| PLRZ | Polyrizon Ltd. | $20.83M | $11.13 | — |
| RVP | RETRACTABLE TECHNOLOGIES INC | $20.96M | $0.70 | — |
News headlines (Yahoo Finance, 1h cache)
Guided Therapeutics Provides Updates on FDA Application Study Results, 2025 Earnings Increase and Successful Warrant Offering
2026-03-31 13:00 · Yahoo
Analysis of Guided Therapeutics' FDA Study Data Reveals Compelling Clinical Need for LuViva
2025-12-17 14:00 · Yahoo
Guided Therapeutics Receives $88,000 Payment as Third Installment of $700,000 Purchase Order with Chinese Distributor
2025-12-11 14:00 · Yahoo
Guided Therapeutics Inks Initial $200,000 Deal with New Distribution Partner Yuanshuo Medical Instruments Corporation
2025-11-19 14:00 · Yahoo
Guided Therapeutics Receives $70,000 -- Its Second of Nine Payments Totaling $700,000 -- from New Chinese Distribution Partner that Provides Products for 2 Million Annual Cervical Cancer Screenings
2025-08-19 13:00 · Yahoo
Guided Therapeutics Provides Update on Completion of US FDA Clinical Trial
2025-08-13 13:00 · Yahoo
Guided Therapeutics Makes Initial Shipment to New Chinese Distribution Partner Hangzhou Dongye Medical Technology, Ltd.
2025-07-02 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.